Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Should TherapeuticsMD Be in Your Portfolio?

Published 04/29/2021, 10:29 AM
Updated 04/29/2021, 11:02 AM
© Reuters.  Should TherapeuticsMD Be in Your Portfolio?

Healthcare stocks have gained prominence due to the pandemic putting an emphasis on the sector. While many large cap companies get their fair share of news, we shouldn't exclude lesser known companies such as TherapeuticsMD Inc . (NASDAQ:TXMD). This pharmaceutical company makes products geared towards women. But is it a stock to buy now? Read more to find out.TherapeuticsMD Inc. (TXMD) is a pharmaceutical business that makes both generic and branded prescription products. The entirety of TXMD's products is geared toward women. In particular, TXMD has been in the news to develop several hormone replacement solutions that mitigate both the health risks and symptoms from hormonal deficiencies stemming from menopause.

Based in Boca Raton, Florida, TXMD dipped in the past month, falling from just under $1.40 to its current price of $1.16. However, TXMD was priced at $2.55 on February 9. The stock quickly descended to $1.30 by early March, jumped to $1.66 by the middle of the month, and has since tailed off.

It is particularly interesting to note TXMD has been in business for more than a century yet is a penny stock. However, this has not always been the case. TXMD was priced as high as $155 in the late aughts. The stock dropped below $5 in 2011, qualifying as a penny stock. TXMD has traded around $8 or less in the decade since.

Continue reading on StockNews

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.